學門類別
政大
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- Leadership Imperatives in an AI World
- Vodafone Idea Merger - Unpacking IS Integration Strategies
- Predicting the Future Impacts of AI: McLuhan’s Tetrad Framework
- Snapchat’s Dilemma: Growth or Financial Sustainability
- V21 Landmarks Pvt. Ltd: Scaling Newer Heights in Real Estate Entrepreneurship
- Did I Just Cross the Line and Harass a Colleague?
- Winsol: An Opportunity For Solar Expansion
- Porsche Drive (B): Vehicle Subscription Strategy
- Porsche Drive (A) and (B): Student Spreadsheet
- TNT Assignment: Financial Ratio Code Cracker
-
Bio-Chem: Time to Veer Off the Path of Centralization?
Dalian Bio-Chem Co. Ltd. (Bio-Chem) had been deeply involved in the field of industrial fungicides for nearly twenty years and occupied a place in both domestic and overseas markets. Since its establishment in 2003, Bio-Chem had adhered to a strategy of centralization, with industrial fungicides as its main business products. Bio-Chem was successfully listed on the A-share market in China in 2012, and it grew rapidly in the ten years that followed. Although Bio-Chem had become a leader in the field of industrial fungicides, its chairman believed that companies should not be content with the status quo. Some within the company believed Bio-Chem should carry out a diversification strategy because it had sufficient funds to do so; others thought it should carry out an integrated strategy because the downstream industry was very profitable; and others thought it should stick to a centralized strategy because the market demand for industrial fungicides was still very large, and adhering to a centralization strategy meant there would be room for growth. The chairman had to consider the opportunities and challenges of each strategy and determine which direction to take the company. -
Bio-Chem: Time to Veer Off the Path of Centralization?
Dalian Bio-Chem Co. Ltd. (Bio-Chem) had been deeply involved in the field of industrial fungicides for nearly twenty years and occupied a place in both domestic and overseas markets. Since its establishment in 2003, Bio-Chem had adhered to a strategy of centralization, with industrial fungicides as its main business products. Bio-Chem was successfully listed on the A-share market in China in 2012, and it grew rapidly in the ten years that followed. Although Bio-Chem had become a leader in the field of industrial fungicides, its chairman believed that companies should not be content with the status quo. Some within the company believed Bio-Chem should carry out a diversification strategy because it had sufficient funds to do so; others thought it should carry out an integrated strategy because the downstream industry was very profitable; and others thought it should stick to a centralized strategy because the market demand for industrial fungicides was still very large, and adhering to a centralization strategy meant there would be room for growth. The chairman had to consider the opportunities and challenges of each strategy and determine which direction to take the company.